Registry for genetic and metabolic liver diseases in China
Official title: A Nation-wide Hospital-based Registry:China Registry for Genetic / Metabolic Liver Diseases
Run by Beijing Friendship Hospital · NCT03131427 · Data updated 2026-11-12
This study is gathering information from patients with genetic or metabolic liver diseases in China to help improve care and support future research.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 20000 (estimated) |
| Sponsor | Beijing Friendship Hospital Academic / other |
| Locations | 12 sites (Beijing, Beijing Municipality and 11 other locations) |
| Status | Recruiting |
| Started | June 13, 2015 |
| Main results expected | April 28, 2022 |
| Study ends | April 28, 2027 |
| Registry record updated | April 27, 2017 |
| Trial ID | NCT03131427 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients diagnosed or suspected of having Wilson's disease, hereditary hemochromatosis, hereditary hyperbilirubinemias, or inherited cholestatic liver disease.
✕Probably not a fit
Patients who are unable or unwilling to provide informed consent will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry collects data on patients diagnosed or suspected to have genetic or metabolic liver diseases, such as Wilson's disease and hereditary hemochromatosis, from various hospitals in mainland China. It records demographics, medical history, laboratory results, and treatment information while also collecting blood samples for genetic testing. Patients are followed up every six to twelve months to monitor their clinical progress and update their medical records. The aim is to create a comprehensive database that can aid in future research and improve patient care.
Why it matters
Potential benefit: If successful, this registry could enhance understanding and management of genetic and metabolic liver diseases, leading to improved patient outcomes.
How similar studies have gone: Other similar registries have shown success in improving patient management and advancing research in genetic diseases.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients who were diagnosed or possibly diagnosed with Wilson's disease, hereditary hemochromatosis, hereditary hyperbilirubinemias, inherited cholestatic liver disease or other genetic/metabolic liver diseases. Exclusion Criteria: Patients who are unable or unwilling to provide informed consent.
Where it's running
-
Beijing Ditan Hospital
Beijing, Beijing Municipality, China Recruiting -
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China Recruiting -
Peking University First Hospital
Beijing, Beijing Municipality, China Recruiting -
Beijing YouAn Hospital
Beijing, Beijing Municipality, China Recruiting -
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, China Recruiting -
Hebei Medical University Third Hospital
Shijiazhuang, Hebei, China Recruiting
Show 6 more locations
-
Henan Provincial Hospital
Zhengzhou, Henan, China Recruiting -
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China Recruiting -
Jinshan Hospital of Fudan University
Shanghai, Shanghai Municipality, China Recruiting -
West China Women's and Children's Hospital, Sichuan University
Chengdu, Sichuan, China Recruiting -
Affiliated Hospital, Logistics University of People's Armed Police Force
Tianjin, Tianjin Municipality, China Recruiting -
Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital
Ürümqi, Xinjiang, China Recruiting
Study contacts
- Principal investigator: Jidong Jia, Doctor — Beijing Friendship Hospital
- Study coordinator: Jidong Jia, MD
- Email: jia_jd@ccmu.edu.cn
- Phone: 010-63139816
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.